Apitope vaccine stops MS in its tracks
UK biopharmaceutical firm Apitope has developed a vaccine that could halt multiple sclerosis in its relentless march to destroy nerve cells.
Archives for November 6, 2007
Contract manufacturing news in brief
Bioserv Corporation, Mikart, Laureate Pharma, Cenexi and Lonza have all recently announced new contract manufacturing news.
New safety warning delays Novartis diabetes drug
Swiss firm Novartis today announced that it has contacted regulators regarding the safety of the 100mg dose of its recently approved Type II diabetes drug, Galvus (vildagliptin).
Why Pfizer's torcetrapib failure might not thwart other CETP inhibitors
It was supposed to keep Pfizer at the top of the cardiovascular drug tree, but when torcetrapib failed, other pharma firms developing similar drugs looked on nervously to see if their drugs were also doomed. A new study suggests they might have...
Varian snaps up Analogix in a flash
Scientific instrument and vacuum technology supplier Varian has acquired the assets of US flash chromatography expert Analogix for $11m (€7.6m) cash plus the assumption of its net debt.
Pharmaceutical patent round-up
In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations.
Tecan and GE join forces to aid HT protein purification
Tecan and GE Healthcare Life Sciences division are collaborating to simplify high throughput (HT) protein purification by increasing the speed and reliability of expression screening programmes.